Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Amphastar Pharmaceuticals Inc (AMPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10168
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s products includes enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; ketorolac tromethamine injection; lidocaine HCl jelly 2%; amphadase hyaluronidase injection; lidocaine HCl 4% topical solution and Luer-Jet prefilled disposable syringes;. Amphastar’s offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Amphastar Pharmaceuticals Inc (AMPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amphastar Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Amphastar Pharma Acquires 14 ANDAs from Hikma Pharma for USD4 Million 11
Amphastar Pharmaceuticals Acquires API manufacturing business of Merck 12
Equity Offering 13
Amphastar Pharma Raises USD40.8 Million in IPO 13
Asset Transactions 15
Athenex Acquires 14 ANDAs and Inventory for Certain APIs from Amphastar Pharma 15
Acquisition 16
Amphastar Pharma Acquires International Medication Systems from UCB Pharma for USD7.7 Million 16
Amphastar Nanjing Pharma Acquires Nanjing Letop Medical Technology USD1.7 Million 17
Amphastar Pharmaceuticals Inc – Key Competitors 18
Amphastar Pharmaceuticals Inc – Key Employees 19
Amphastar Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Strategy And Business Planning 22
Jul 09, 2018: Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals 22
Financial Announcements 23
Aug 08, 2018: Amphastar Pharmaceuticals reports financial results for the three months ended june 30, 2018 23
May 09, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018 25
Mar 12, 2018: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017 26
Nov 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017 28
Aug 09, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017 30
May 08, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017 31
Mar 13, 2017: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016 33
Legal and Regulatory 35
Mar 21, 2018: Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals and Sandoz 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amphastar Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Amphastar Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amphastar Pharma Acquires 14 ANDAs from Hikma Pharma for USD4 Million 11
Amphastar Pharmaceuticals Acquires API manufacturing business of Merck 12
Amphastar Pharma Raises USD40.8 Million in IPO 13
Athenex Acquires 14 ANDAs and Inventory for Certain APIs from Amphastar Pharma 15
Amphastar Pharma Acquires International Medication Systems from UCB Pharma for USD7.7 Million 16
Amphastar Nanjing Pharma Acquires Nanjing Letop Medical Technology USD1.7 Million 17
Amphastar Pharmaceuticals Inc, Key Competitors 18
Amphastar Pharmaceuticals Inc, Key Employees 19
Amphastar Pharmaceuticals Inc, Other Locations 20
Amphastar Pharmaceuticals Inc, Subsidiaries 20

List of Figures
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amphastar Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Strand Life Sciences Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequenc …
  • Korea Western Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Western Power Co., Ltd. (KOWEPO), a subsidiary of Korea Electric Power Corporation (KEPCO), develops electricity resources, and generates and supplies electricity. The company’s power generation portfolio includes Taen, Pyeongtaek, Seoincheon, and Gunsan power complexes consisting of t …
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Indeck Energy Services Inc:企業の戦略的SWOT分析
    Indeck Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Lonestar Resources US, Inc. (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務情報
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UCL Business PLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the trans …
  • Lynntech Inc:企業の製品パイプライン分析
    Summary Lynntech Inc (Lynntech) is a diversified company. The company designs, fabricates and refines fuel cell test stations for research. It conducts research and development in the areas of energy, power, life sciences, materials science, therapeutics and diagnostics, chemical and environmental s …
  • ATCC-製薬・医療分野:企業M&A・提携分析
    Summary ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other ma …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • Zara Investment (Holding) Co Ltd
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Yuanta Financial Holding Co., Ltd.:戦略・SWOT・企業財務分析
    Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yuanta Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) is a technology company that carries out manufacturing of electron tube. The company offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equip …
  • Schweiter Technologies AG (SWTQ):企業の財務・戦略的SWOT分析
    Summary Schweiter Technologies AG (Schweiter) is a technology company that develops, manufactures and commercialize composite panels and core materials for sandwich constructions. The company’s business category includes core materials, architecture, display and transportation. It SSM textile machin …
  • Ratchaburi Electricity Generating Holding Public Co Ltd (RATCH):電力:M&Aディール及び事業提携情報
    Summary Ratchaburi Electricity Generating Holding Public Company Limited (RATCH) is an independent power producer. Through investments in subsidiaries, associates and joint ventures, the company operates electricity generating and related businesses. It operates independent power producing and small …
  • Adani Enterprises Ltd (ADANIENT)
    Adani Enterprises Ltd (ADANIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務分析
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Schroders plc:戦略・SWOT・企業財務分析
    Schroders plc - Strategy, SWOT and Corporate Finance Report Summary Schroders plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Metals X Limited:企業の戦略・SWOT・財務情報
    Metals X Limited - Strategy, SWOT and Corporate Finance Report Summary Metals X Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Anthem Inc (ANTM):製薬・医療:M&Aディール及び事業提携情報
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers managed healthcare related products and administrative services. The company provides various specialty and insurance products and services including radiology benefit management, dental, life and disability …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆